BRAIN Initiative Optimization of Novel Tools and Technologies for Neuroscience Research (R44) | Apply Online

Frequently Asked Questions (FAQs)

1) What is the BRAIN Initiative Optimization of Novel Tools and Technologies for Neuroscience Research (R44) opportunity?

This funding opportunity (PAR 15-121) is an NIH Small Business Innovation Research (SBIR) program designed to help small businesses further develop neuroscience tools and technologies. The emphasis is on optimizing and maturing technologies so they become more usable, more scalable, and more broadly adoptable by the neuroscience research community.

2) What is the main goal of this grant program?

The core goal is to move promising neuroscience technologies beyond early proof-of-concept into a more refined, widely usable form. NIH is aiming for outcomes that can be disseminated broadly and that can ultimately become part of routine neuroscience research practice.

3) Is this grant intended to support brand-new, untested ideas?

No. The program is described as focusing on iterative refinement and accelerated development of tools that have already demonstrated transformative potential, rather than funding entirely new and untested concepts.

4) What funding mechanism does this opportunity use?

This opportunity uses the R44 mechanism, which corresponds to SBIR Phase II awards administered by the National Institutes of Health (NIH).

5) Who administers this grant program?

The program is administered by the National Institutes of Health (NIH).

6) Who is eligible to apply?

Eligibility is limited to small businesses.

7) Are non-U.S. (foreign) organizations eligible to apply?

No. Non-U.S. (foreign) organizations are not eligible to apply for this opportunity.

8) Can a U.S. small business include non-U.S. components in its application?

Non-U.S. components of U.S. organizations are not eligible. However, foreign components (as defined in the NIH Grants Policy Statement) may be allowable in some situations, typically when parts of the work are conducted abroad with appropriate justification and in compliance with NIH policy.

9) Is cost sharing or matching funding required?

No. There is no cost sharing or matching requirement, meaning applicants are not required to provide matching funds as a condition of receiving an award.

10) What scientific or technical areas does NIH want to support through this FOA?

The FOA highlights two major needs in modern brain research: (1) technologies and novel approaches for large-scale recording and manipulation of neural activity at or near cellular resolution, and (2) tools that support detailed analysis of complex neural circuits and help reveal cellular interactions underlying brain function.

11) What kinds of neural recording and manipulation capabilities are emphasized?

NIH is looking for optimized technologies that enable large-scale recording and manipulation of neural activity at or near cellular resolution, operate across multiple spatial and temporal scales, function in any brain region, and access signals throughout the full depth of the brain (not only superficial areas).

12) What limitations of existing methods is this opportunity trying to address?

The description points to constraints in current methods related to resolution, depth, coverage, speed, and scalability. The FOA encourages next-generation ways to observe and control neural activity more comprehensively and precisely, including in more realistic experimental contexts.

13) What kinds of circuit analysis tools does this FOA emphasize?

The FOA emphasizes technologies and approaches that help interpret high-dimensional neuroscience datasets, map circuit organization, and link cellular-level events to circuit-level computations and behavior.

14) How broadly applicable are the technologies supported by this FOA across NIH missions?

The opportunity is linked to multiple CFDA areas spanning neuroscience and neurological disorders, mental health, aging, addiction, alcohol research, and communication disorders, reflecting that BRAIN-enabled technologies can be broadly applicable across NIH priorities.

15) What type of program is this in terms of federal grant classification?

It is described as a discretionary grant program administered by NIH, categorized under education and health-related research.

16) When was this opportunity posted and when did it close?

The opportunity was posted in February 2015, originally closed in April 2015, remained open through a later closing date in January 2017, and was archived in February 2017.

17) Is this funding opportunity still active?

No. Based on the provided dates, it was archived in February 2017.

18) Where was the full announcement hosted?

The full announcement was hosted on the NIH grants website.

19) Who should be contacted for access or technical issues with the announcement?

For access or technical issues related to the announcement, the listed contact is the NIH Office of Extramural Research (OER) webmaster email.

20) What is NIH expecting in terms of dissemination and adoption?

The program description emphasizes broad dissemination of the resulting products and methods, with the expectation that they will eventually become part of routine neuroscience research practice.